Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage 2018-01-01
  2. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients 2016-11-01
  3. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease 2016-05-24

Studies

6 studies carry this tag.

Date range

2004 to 2018

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • Advanced drug delivery reviews 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Glia 1
  • Science translational medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Journal of Alzheimer's disease : JAD 2018-01-01 Biomarkers

    Inflammatory markers have been shown to predict neurocognitive outcomes in aging adults; however, the degree to which peripheral markers mirror the central nervous system remains unknown.

  2. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Science translational medicine 2016-11-01 Tau biomarkers

    β-Amyloid (Aβ) peptides are thought to be critically involved in the etiology of Alzheimer's disease (AD).

  3. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2016-05-24 Tau biomarkers

    Tau is readily transported from the brain to the blood.

  4. Nanotechnological advances for the delivery of CNS therapeutics

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Advanced drug delivery reviews 2011-11-07 Tau biomarkers

    Effective non-invasive treatment of neurological diseases is often limited by the poor access of therapeutic agents into the central nervous system (CNS).

  5. Uric acid as a CNS antioxidant

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of Alzheimer's disease : JAD 2010-01-01 Tau biomarkers

    Oxidative damage is a consistent finding in a number of central nervous system (CNS) disorders.

  6. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Glia 2004-11-01 Biomarkers

    Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment.

All topic tags with their study counts